Mirae Asset Global Investments Co., Ltd. Precigen, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Precigen, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 9,759 shares of PGEN stock, worth $12,686. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,759
Previous 10,406
6.22%
Holding current value
$12,686
Previous $9,000
11.11%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PGEN
# of Institutions
141Shares Held
161MCall Options Held
232KPut Options Held
69K-
Third Security, LLC83.5MShares$109 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD17.9MShares$23.3 Million0.92% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA10.9MShares$14.1 Million0.02% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$13.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.33MShares$10.8 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $271M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...